Alternative end-joining catalyzes class switch recombination in the absence of both Ku70 and DNA ligase 4 by Boboila, Cristian et al.
Article
The Rockefeller University Press  $30.00
J. Exp. Med. Vol. 207 No. 2  417-427
www.jem.org/cgi/doi/10.1084/jem.20092449
417
There are two well-characterized mammalian 
DSB repair pathways. Homologous recombi-
nation accurately repairs post-replicative DSBs 
via a long, homologous template from a sister 
chromatid, whereas nonhomologous end join-
ing (C-NHEJ) fuses DSB ends that lack sub-
stantial junctional homology (Bassing and Alt, 
2004). Thus, C-NHEJ is particularly important 
during the G1 cell cycle phase when homolo-
gous templates from sister chromatids are not 
available (Lieber et al., 2008). Studies of the   
repair of RAG endonuclease-generated DSBs, 
in the context of lymphocyte-specific V(D)J 
recombination, were critical for elucidation of 
C-NHEJ. In this context, V(D)J recombina-
tion is abrogated in the absence of any of the 
four evolutionarily conserved “core” C-NHEJ 
factors, including Ku70, Ku80, XRCC4, and 
Lig4 (Taccioli et al., 1994; Li et al., 1995; Gu 
et al., 1997; Frank et al., 1998). Ku70 and Ku80 
form the “Ku” DNA end-binding complex 
which functions as the DSB recognition com-
ponent  of  C-NHEJ,  whereas  the  XRCC4/
Lig4 complex is specific for C-NHEJ ligation. 
DNA-dependent protein kinase catalytic sub-
unit (DNA-PKcs) and the Artemis endonucle-
ase are nonevolutionarily conserved C-NHEJ 
factors. Ku and DNA-PKcs form the DNA-PK 
holoenzyme, which, upon Ku binding to DSBs, 
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The classical nonhomologous end-joining (C-NHEJ) DNA double-strand break (DSB)  
repair pathway employs the Ku70/80 complex (Ku) for DSB recognition and the XRCC4/
DNA ligase 4 (Lig4) complex for ligation. During IgH class switch recombination (CSR) in  
B lymphocytes, switch (S) region DSBs are joined by C-NHEJ to form junctions either with 
short microhomologies (MHs; “MH-mediated” joins) or no homologies (“direct” joins). In the 
absence of XRCC4 or Lig4, substantial CSR occurs via “alternative” end-joining (A-EJ) that 
generates largely MH-mediated joins. Because upstream C-NHEJ components remain in 
XRCC4- or Lig4-deficient B cells, residual CSR might be catalyzed by C-NHEJ using a 
different ligase. To address this, we have assayed for CSR in B cells deficient for Ku70, 
Ku80, or both Ku70 and Lig4. Ku70- or Ku80-deficient B cells have reduced, but still 
substantial, CSR. Strikingly, B cells deficient for both Ku plus Lig4 undergo CSR similarly  
to Ku-deficient B cells, firmly demonstrating that an A-EJ pathway distinct from C-NHEJ 
can catalyze CSR end-joining. Ku-deficient or Ku- plus Lig4-deficient B cells are also 
biased toward MH-mediated CSR joins; but, in contrast to XRCC4- or Lig4-deficient  
B cells, generate substantial numbers of direct CSR joins. Our findings suggest that more 
than one form of A-EJ can function in CSR.
© 2010 Boboila et al.  This article is distributed under the terms of an Attribu-
tion–Noncommercial–Share Alike–No Mirror Sites license for the first six months 
after the publication date (see http://www.rupress.org/terms). After six months 
it  is  available  under  a  Creative  Commons  License  (Attribution–Noncommer-
cial–Share Alike 3.0 Unported license, as described at http://creativecommons 
.org/licenses/by-nc-sa/3.0/).
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proliferation (Rush et al., 2005), an alternative, not mutually 
exclusive, possibility is that the previously reported severe 
proliferation defects of Ku-deficient B cells led indirectly to 
impaired CSR (Manis et al., 1998; Reina San-Martin et al., 
2003; Chaudhuri and Alt, 2004; Chaudhuri et al., 2007).   
In this context, substantial end joining of chromosomal ISceI-
initiated DSBs occurs in Ku-deficient cells (Guirouilh-Barbat 
et al., 2004, 2007).
C-NHEJ can join both DSB ends that lack junctional 
MH to form “direct” joins and DSBs ends with very short 
stretches of junctional homology to form microhomology 
(MH)-mediated joins. Correspondingly, both V(D)J recom-
bination and CSR junctions generated in C-NHEJ-proficient   
B cells show substantial numbers of direct joins (up to 50%), 
with the remainder mostly containing short (1-2 bp) junc-
tional MHs (Gilfillan et al., 1993; Komori et al., 1993). How-
ever, essentially all CSR junctions in XRCC4-deficient   
B cells contain MH which are, on average, longer than those 
observed in normal CSR junctions (Yan et al., 2007). Studies 
of XRCC4- or Lig4-deficient cells also revealed increased 
usage of MH in plasmid circularization junctions (Kabotyanski 
et al., 1998), ISceI DSB junctions (Guirouilh-Barbat et al., 
2007), oncogenic translocation junctions (Zhu et al., 2002; 
Wang et al., 2008, 2009), and V(D)J junctions (Corneo   
et al., 2007). Such findings have led to the description of   
A-EJ as MH-mediated end joining (McVey and Lee, 2008). 
Yet,  outside  of  CSR,  end-joining  events  in  the  absence   
of XRCC4 do not exclusively use MH (Kabotyanski et al., 
1998; Corneo et al., 2007; Guirouilh-Barbat et al., 2007). 
Moreover, in Ku80-deficient cells, A-EJ of ISceI-initiated 
DSBs generates a substantial proportion of direct junctions 
(Guirouilh-Barbat et al., 2004, 2007). Conceivably, the rela-
tive  predominance  of  MH-mediated  junctions  in  various   
A-EJ  studies  might  reflect  differences  in  substrates  used, 
which in turn might influence pathway choice and junctions 
by providing differing degrees of MH (Yan et al., 2007).   
Alternatively,  but  not  mutually  exclusively,  there  may  be   
different A-EJ pathways with distinct MH requirements and 
differential dependence on Ku versus XRCC4/Lig4. In the 
latter context, the relatively robust CSR observed in XRCC4 
and Lig4 deficient B cells (Yan et al., 2007, Corneo et al., 
2007) has been proposed to potentially represent a less effi-
cient form of C-NHEJ that uses all of the C-NHEJ upstream 
components but a different DNA ligase (Lieber et al., 2008).
To unequivocally determine whether CSR can be cata-
lyzed by an A-EJ pathway that is distinct from C-NHEJ, we 
have now assayed for CSR in B cells that lack Ku70, Ku80 or 
both Ku70 and Lig4.
RESULTS
Ku-independent IgH class switching
Several independent studies from more than a decade ago re-
ported that Ku70- or Ku80-deficient B cells had very severe 
CSR defects (Manis et al., 1998; Casellas et al., 1998), leading 
to the assumption that, as in V(D)J recombination, CSR end-
joining is catalyzed strictly by C-NHEJ (Honjo et al., 2004). 
phosphorylates Artemis, which can then process a subset of   
DSBs, including the hairpin coding ends generated during 
V(D)J recombination (Lieber et al., 2008). C-NHEJ also 
plays a key role in general DSB repair, as indicated by the 
impaired DSB repair, increased radiosensitivity and marked 
genomic instability of C-NHEJ–deficient cells (Rooney   
et al., 2004). Yet, studies of C-NHEJ deficient mamma-
lian cells have revealed a still poorly characterized, but sur-
prisingly robust, alternative end-joining (A-EJ) mechanism.
Early evidence for A-EJ came from linear plasmid rejoin-
ing assays using Ku-, Xrcc4-, or Lig4-deficient cell lines 
(Boulton and Jackson, 1996; Kabotyanski et al., 1998; Wang 
et al., 2003), and interest in A-EJ was stimulated by findings 
that it fuses chromosomal DSBs to generate oncogenic trans-
locations in lymphomas from Xrcc4- or Lig4-deficient mice 
that were also deficient for p53 (Roth, 2002; Zhu et al., 2002). 
More recently, A-EJ was found to join ISceI endonuclease-
generated DSBs in substrates chromosomally integrated into 
C-NHEJ-deficient cells (Guirouilh-Barbat et al., 2004, 2007) 
and to join physiologically relevant Ig heavy chain (IgH) class 
switch recombination (CSR)-associated DSBs in C-NHEJ 
deficient mouse B cells (Soulas-Sprauel et al., 2007; Yan   
et al., 2007; Han and Yu, 2008). Moreover, the absolute   
dependence of V(D)J recombination on core C-NHEJ factors 
was found to result from RAG endonuclease channeling the 
reaction into C-NHEJ and excluding A-EJ (Corneo et al. 
2007; Deriano et al., 2009). Thus, A-EJ clearly appears to be 
a relevant chromosomal end joining mechanism. Yet, A-EJ and 
its  components  remain  largely  uncharacterized,  and  A-EJ 
might represent more than one pathway. With respect to 
components, the Xrcc1/Ligase 3 base excision repair ligation 
complex has been implicated in extra-chromosomal A-EJ, but 
potential roles in chromosomal A-EJ are unknown (Wang   
et al., 2003; Audebert et al., 2004). In addition, very recent 
studies have implicated the MRN complex in both C-NHEJ 
and A-EJ (Deng et al., 2009; Deriano et al., 2009; Dinkelmann 
et al., 2009; Rass et al., 2009; Xie et al., 2009), potentially via 
an end-processing function in A-EJ by itself and/or indirectly 
via the DSB response (Zha et al., 2009).
CSR provides a useful model for studies of chromosomal 
A-EJ. CSR in activated mature B lymphocytes exchanges the 
C IgH constant region (CH) exons for one of several sets   
of CH exons (e.g., C, C, and C) that lie 100 to 200kb 
downstream (Chaudhuri et al., 2007). Long, repetitive switch 
(S) regions lie just upstream of each set of CH exons. Activa-
tion-induced cytidine deaminase (AID) initiates CSR by 
generating lesions that lead to multiple DSBs in the donor   
S region flanking C (S) and in a downstream acceptor S 
region. CSR is completed when a DSB in S is end-joined 
to a DSB in a downstream S region. Several different studies 
found that CSR was abrogated by Ku70- and/or Ku80-
deficiency  (Casellas  et  al.,  1998;  Manis  et  al.,  1998).  To   
resolve  these  findings  with  the  relatively  robust  CSR  via   
A-EJ in XRCC4- and Lig4-deficient B cells (Yan et al., 2007), 
one might speculate that Ku functions in both C-NHEJ and 
A-EJ during CSR. However, given that CSR requires B cell JEM VOL. 207, February 15, 2010 
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goes normal CSR (Casellas et al., 1998; Manis et al., 1998; 
Yan et al., 2007). Because of the complex breeding strategies 
necessary to generate these mice, we generated Ku70/ and 
Ku80/ strains that were either homozygous or heterozy-
gous for the B1-8-HC knock-in allele (referred to, respec-
tively, as H/HL and H/+L). The breakdown of results with 
these genotypes is indicated in each figure or in supplemen-
tary figures and tables. Because H/HL and H/+L lines gave 
similar results for most experiments, we generically refer to 
both genotypes as HL mice, except where otherwise noted. 
We verified homozygous disruption of the Ku70 and Ku80 
locus and the absence of the Ku70 protein in the Ku70/HL 
mice and cells analyzed (Fig. 1 a and not depicted).
Ku70/HL and Ku80/HL mice generate substantial 
numbers of mature splenic B cells, which express surface Ig 
that derives from their IgH and Ig knock-in alleles (Fig. 1 b). 
To test CSR potential to IgG1 and IgE, we purified Ku70/ 
HL and Ku80/HL splenic B cells and stimulated them for 
4 d with CD40 plus IL-4 or, for some experiments, with 
bacterial LPS plus IL-4. In contrast to earlier findings, neither 
the Ku70/ nor Ku80/ B cells showed a dramatic prolif-
eration defect compared with control cells (Fig. 1 c and not 
depicted). Under these stimulation conditions, up to 50–60% 
of WT/HL B cells switched to IgG1 as measured by flow   
However, normal CSR requires B cell proliferation, and pre-
viously studied Ku70- or Ku80-deficient B cells had severe 
proliferation defects, with many dying when activated for 
CSR (Casellas et al., 1998; Manis et al., 1998; Reina San-
Martin et al., 2003). Therefore, we have suggested that   
although Ku70 and Ku80 are required for normal CSR, their 
overall contribution via C-NHEJ remained to be determined 
(Manis et al., 2002; Chaudhuri and Alt, 2004; Chaudhuri   
et al., 2007). Our current protocols for activating B cells 
stimulate much higher CSR levels in WT B cells than those 
used in the original Ku70/ and Ku80/ B cell studies; 
e.g., in the earlier studies of Ku-deficient cells, only 10% of 
WT B cells underwent CSR to IgG1 (Casellas et al., 1998; 
Manis et al., 1998), whereas under current stimulation condi-
tions (different purification of cells, sources of cytokines, and 
activators, etc.) we observe CSR to IgG1 in 60% or more of 
WT B cells (Cheng et al., 2009; see Fig. 2). Therefore, we 
have reexamined the requirement for Ku70 and Ku80 in 
CSR. As Ku70 and Ku80 are required for V(D)J recombina-
tion and generation of mature B cells, we generated Ku70/ 
or Ku80/ mice that harbored preassembled (“knock-in”) 
IgH (B1-8-HC) and IgL (3–83k-LC) variable region exons 
(Pelanda et al., 1997; Sonoda et al., 1997). Various studies 
have shown that the B1-8-HC V(D)J knock-in allele under-
Figure 1.  Ku70/HL and Ku70/Lig4/HL mice posses mature splenic B cells which proliferate in response to stimulation by CD40/IL-4. 
(a) Disruption of the Ku70 and Lig4 genomic loci and absence of Ku70 and Lig4 proteins in Ku70/Lig4/ mice. (left) Southern blotting: BamHI-digested 
genomic DNA was probed with Ku70- or Lig4-specific probes. (right) Thymus protein extracts were assayed for the presence of Ku70 or Lig4 proteins.  
K, kidney protein extracts; BM, bone marrow protein extracts. Both the Southern and the Western blotting were repeated two times on independent  
samples. (b) WT-HL, Ku70/HL and Ku70/Lig4/HL mice have mature splenic B cells. Whole cell suspensions from spleens of WT-HL, Ku70/HL, and 
Ku70/Lig4/HL were used to quantify the percentage of B220+IgM+ mature B cells. Data shown are representative of more than 10 experiments, with 
at least one mouse of each genotype per experiment. (c) Ku70/HL mature B cells proliferate at levels comparable to WT-HL after CD40/IL-4 stimula-
tion. Splenic B cells were enriched with B220 magnetic beads and counted by Trypan blue staining starting at day 1.5 from the beginning of the culture, 
to allow for the disappearance of non–B cells. Data shown are based on two independent stimulations and a total of 4 WT-HL and 5 Ku70/HL mice 
were used. Error bars are based on the relative cell number for each mouse.420 Ku influences CSR in the absence of DNA ligase 4 | Boboila et al.
because  of  binding  of  secreted  IgE  to  Fc  receptors  on   
B cells. However, ELISA demonstrated that Ku70/HL   
B cells switched to IgE at 25% of WT/HL levels (Fig. 2 b). 
Moreover, hybridoma analyses revealed that 50% of WT/
HL B cells switched to IgE under our current stimulation 
conditions and that Ku70/HL B cell hybridomas switched 
to IgE at 30% of WT/HL levels, which is consistent with 
the ELISA data (Table S3). Note that because the WT hy-
bridomas were derived from the H/HL+ genotype, 15% 
were  IgE/IgG1  double  producers  caused  by  productive 
CSR to IgG1 on one allele and to IgE on the other (see   
Table  S3  legend).  Finally,  the  hybridoma  analyses  also   
allowed  us  to  confirm  IgE  CSR  at  the  DNA  level  via   
Southern blotting (Fig. S2). Thus, these studies implicate   
a relatively robust Ku-independent form of A-EJ that sup-
ports CSR to IgG1 and IgE.
cytometry staining for surface IgG1 expression (Fig. 2 a, 
Fig. S1, and Table S1). Strikingly, however, the surface 
staining assay also revealed that CD40 plus IL-4 or LPS 
plus IL-4–stimulated Ku70/HL B cells and Ku80/HL 
B cells underwent CSR to IgG1 at levels 20–50% of those 
of WT/HL B cells (Fig. 2 a, Fig. S1, and Table S1). We 
confirmed  the  unexpected  CSR  ability  of  Ku70/  and 
Ku80/ B cells by using numerous additional types of class 
switching assays, including measurement of secreted IgG1 
by ELISA (Fig. 2 b and Table S2), as well as by the more 
quantitative clonal B cell ELISPOT (not depicted) or hy-
bridoma IgG1 secretion analyses (Fig. 2 c and Table S3). 
Southern blotting also allowed us to confirm that CSR in 
Ku70/HL B cell hybridomas occurred at the DNA level 
via S to S1 recombination (Fig. S2). IgH class switching 
to IgE cannot be assayed quantitatively via surface staining 
Figure 2.  High IgG1 and IgE CSR levels in Ku70/, Ku70/Lig4/, Ku80/, and Lig4/ B cells. (a) Representative FACS panel for IgG1 CSR 
in B cells stimulated with CD40 plus IL-4 and assayed at day 3.5. Data shown are representative of >10 experiments, with one or more mouse of each 
genotype per experiment. Table S1 contains a summary of all FACS experiments. (b) ELISA quantification of IgM, IgG1, and IgE secretion (G/ml) in B cells 
stimulated as in a. Black circles, H/H (the knock-in prerearranged heavy chain receptor is present on both alleles); white circles, H/+ (knock-in heavy  
chain on one allele). All experiments completed are shown, with one mouse per genotype per experiment and each circle represents one mouse. Table S2  
contains a detailed summary of all ELISA experiments. (c) Frequency of IgG1-secreting hybridomas generated from CD40/IL-4–stimulated B cells.  
Hybridomas for one mouse per genotype are shown. The number and percentage of hybridomas is indicated for each isotype assayed. “Other” denotes 
hybridomas negative for both IgM and IgG1 secretion, some of which may be IgE+ because IgE ELISA was not performed for the fusions shown. Data 
shown are representative of three independent hybridoma fusion experiments (one mouse each) for WT-HL and Ku70/HL and two independent hybrid-
oma fusions (one mouse each) for the Ku70/Lig4/HL mice. Table S3 contains a summary of all hybridoma data, with multiple mice of each genotype.JEM VOL. 207, February 15, 2010 
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robustly than treatment with LPS alone (Cheng et al., 2009). 
Therefore, to test CSR to these two IgH isotypes, we stim-
ulated purified Ku70/HL splenic B cells for 4 d with LPS 
plus anti–IgD-dextran. Based on the flow cytometry assay 
for surface IgG3 expression, this stimulation led to IgG3 
switching in up to 40% of the WT/HL B cells (Fig. 3 a;   
Table S1). Strikingly, Ku70/HL B cells underwent class 
switching to IgG3 on average at nearly 30% of WT levels 
under these conditions (Fig. 3 a and Table S1). LPS plus 
anti–IgD-dextran  treatment  of  Ku70/HL  B  cells  also   
induced switching to IgG3 at a substantial fraction of WT/
HL levels, based on ELISA and ELISPOT analyses (Fig. 3, 
b and c, and Table S2) and to IgG2b based on ELISA analy-
ses (Fig. 3 b and Table S2). A more limited set of studies 
DNA-PKcs–deficient  B  cells  appear  more  impaired   
for CSR to other IgH isotypes than for CSR to IgG1   
(Manis et al., 2002; Rooney et al., 2005; Callén et al., 2009). 
Therefore, because Ku functions in part via its role in the 
DNA–PK complex, we assessed the ability of Ku70/HL 
or Ku80/HL B cells to undergo CSR to additional IgH 
isotypes.  Stimulation  of  splenic  B  cells  with  LPS  alone   
induces CSR to IgG2b and IgG3. However, we have re-
cently shown that DNA-PKcs– or Artemis-deficient B cells 
activated for CSR are much more prone to cell death upon 
LPS stimulation compared with stimulation with CD40 
plus IL-4 because of a p53-dependent response to unre-
paired DNA DSBs (Franco et al., 2008). LPS plus anti–IgD-
dextran stimulates class switching to IgG2b and IgG3 more 
Figure 3.  Ku70- and Ku70/Lig4-deficient cells undergo robust CSR to IgG3 and IgG2b. (a) Representative FACS panel for IgG3 CSR in B cells 
stimulated with LPS and anti–IgD-dextran and assayed at day 3.5. Data shown are representative of >10 experiments, with one or more mouse of each 
genotype per experiment. Table S1 contains a summary of all FACS experiments. (b) ELISA quantification of IgM, IgG3, and IgG2b secretion (micrograms/
milliliter) in B cells stimulated as in a. Black circles, H/H (the knock-in prerearranged heavy chain receptor is present on both alleles); white circles: H/+ 
(knock-in heavy chain on one allele). Each circle represents one mouse. All experiments completed are shown, with one mouse per genotype per experi-
ment. Table S2 contains a summary of all ELISA experiments. (c) Representative ELISPOT assay on B cells stimulated as in A. (top) Dots represent Ig- and 
Ig-secreting B cells. (bottom) Dots represent IgG3-secreting B cells. Percentages of B cells undergoing CSR to IgG3 are shown. Data shown are represen-
tative of three experiments, with one mouse of each genotype per experiment.422 Ku influences CSR in the absence of DNA ligase 4 | Boboila et al.
et al., 2009). These studies showed that Ku70/HL and 
Ku70/Lig4/HL  B  cells  underwent  class  switching  to 
IgG1 at a significant fraction of the level observed in WT/
HL B cells at all assayed time points (Fig. 4, a and b, Fig. S1, 
and Table S1). Thus, the Ku70- and Ku70/Lig4-indepen-
dent pathway of IgH class switching to IgG1 also is relatively 
robust kinetically as compared with that of WT/HL B cells. 
However, the relative level of class switching to IgG1 for 
Ku70/B cells and Ku70/Lig4/HL B cells, as compared 
with that of WT/HL B cells, appeared slightly lower on   
average at day 2.5 versus later time points (Fig. 4 b and Table S1),   
suggesting that CSR in the absence of Ku70 might be slightly 
less robust kinetically than that of CSR in WT cells (Yan   
et al., 2007). In this regard, while CSR in B cells in which 
XRCC4 was conditionally deleted in the periphery appeared 
kinetically similar to that of WT B cells (Yan et al., 2007), 
CSR in a Lig4-deficient B cell line appeared kinetically 
reduced (Han and Yu, 2008).
CSR junctional sequences in Ku70 or Ku70 plus  
Lig4-deficient B cells
A substantial fraction of CSR junctions from WT B cells are 
direct,  with  most  of  the  remainder  displaying  short  MHs; 
whereas essentially all CSR junctions from XRCC4-deficient 
B cells display MHs that are on average longer than those from 
WT B cells (Yan et al., 2007). To further assess the relationship 
between the A-EJ pathway that generates CSR joins in Ku-
deficient  cells  versus  that  which  occurs  in  the  absence  of 
XRCC4 or Lig4, we sequenced S/S1 and S/S junctions 
from  Ku70/HL,  Ku70/Lig4/HL,  Lig4/HL,  and 
WT/HL splenic B cells that were activated with CD40 plus 
IL-4. As expected, a substantial percentage of S/S1 and S/
S junctions from WT/HL B cells were direct (27.1 and 33.3% 
direct, respectively; Fig. 5, b and c, and Table S4). On the 
other hand, S/S1 and S/S junctions from Lig4/HL   
B cells were almost all MH-mediated (2 and 0% direct, respec-
tively), consistent with the fact that XRCC4 and Lig4 act as a 
complex in C-NHEJ. Although S/S1 and S/S junctions 
from Ku70/HL B cells also displayed increased usage and 
mean length of MH-mediated joins compared with those from 
WT/HL B cells (Fig. 5, b and c; Table S4), a substantial frac-
tion were direct (8.9 and 12.2%, respectively; Fig. 5, b and c; 
Table S4). Similarly, a substantial fraction of S/S1 and S/
S junctions from Ku70/Lig4/HL B cells also were direct 
(18 and 13%, respectively; Fig. 5, b and c, and Table S4). Thus, 
CSR junctions in Ku-deficient B cells, whether or not Lig4   
is present, show a substantial and significant increase in direct 
joins as compared with junctions generated in the absence of 
Lig4 (P = 0.04 for Ku70/HL; P = 0.003 for Ku70/Lig4/ 
HL; Fig. 5 C and Table S4). Importantly, the fraction of direct 
joins is not significantly different between Ku70 versus Ku70 
plus Lig4-deficient B cells (P = 0.11 for S/S1 and P = 0.96 
for S/S junctions; Fig. 5 C), which is consistent with the 
possibility that another ligase may be predominantly used for 
CSR end-joining in Ku70/HL B cells.
also demonstrated that LPS-stimulated Ku80/HL B cells 
switch to IgG3 or IgG2b, as assayed by flow cytometry   
(Table S1), ELISPOT (not depicted), or ELISA (Table S2). 
Finally, we used stimulation with LPS–IL-4–IL-5 and TGF 
for class switching to IgA and found that Ku70/HL B cells 
also switched to IgA at levels that were a substantial fraction 
of those observed for WT/HL B cells (Fig. S3).
Class switching in B cells lacking both Ku70 and Lig4
Although Lig4 deficiency is embryonically lethal (Frank et al., 
1998), Ku80/Lig4/ mice (Karanjawala et al., 2002) and   
Ku70//Lig4/ DT40 avian cell lines (Adachi et al., 2001) 
are viable. In addition, we find that Ku70/Lig4/ mice 
are also viable (see below). Thus, we addressed the question 
of whether CSR can occur in a fully C-NHEJ–independent 
fashion by asking whether we observe CSR in cells deficient 
for both Ku70 and Lig4 (the specific DSB recognition and   
ligation C-NHEJ components). For this purpose, we gener-
ated Ku70/Lig4/ mice, which also harbored the pre-
assembled  IgH  and  IgK  alleles  (HL).  Ku70/Lig4/HL 
mice  develop  normally,  albeit  being  slightly  smaller  than   
their littermates. We confirmed the deletion of Ku70 and 
Lig4 genes and absence of both proteins in extracts from   
kidney, brain and thymus by Southern blotting and Western 
blotting, respectively (Fig. 1 a). Ku70/Lig4/HL mice 
also generate IgM+ splenic B cells (Fig. 1 b), but lack mature 
thymic or peripheral T cells because of their V(D)J recombi-
nation block (not depicted). To test for ability of purified 
Ku70/Lig4/HL splenic B cells to undergo class switch-
ing, we stimulated them for 4 d with CD40 plus IL-4 and 
measured  class  switching  to  IgG1  by  surface  staining  and 
ELISA (Fig. 2, a and b, Table S1, and Table S2). We also 
stimulated Ku70/Lig4/HL splenic B cells for 4 d with 
LPS plus anti–IgD-dextran and measured class switching to 
IgG3 and IgG2b by surface staining, ELISA, and ELISPOT 
(Fig. 3, a–c, Table S1, and Table S2). Based on all of these   
assays, Ku70/Lig4/HL B cells showed class switching 
to all tested IgH isotypes at levels comparable to Ku70/ B 
cells. Therefore, we conclude that there is a repair pathway 
that catalyzes substantial IgH class switching in the com-
plete absence of C-NHEJ.
CSR is less robust in the absence of Ku70 versus ligase 4
Most studies of CSR tend to measure this process at time 
points after stimulation (e.g., day 4) when WT CSR is nearly 
complete. However, measurements at such late time points 
might underestimate kinetic differences between mutant and 
WT B cells, by allowing the mutant B cells to “catch up” 
(Cheng et al., 2009). Therefore, to further characterize the 
Ku-independent A-EJ pathway during CSR, we performed 
time-course kinetics of class switching to IgG1 in CD40 
plus IL-4 stimulated HL, Ku70/HL and Ku70/Lig4/HL 
purified splenic B cells. For this purpose, we measured   
surface IgG1expression at days 2.5, 3.5, and 4.5, with the 
earliest time point corresponding to about the time that AID 
expression is readily detectable in stimulated B cells (Cheng JEM VOL. 207, February 15, 2010 
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new insights into A-EJ. In particular, we now demonstrate 
that, in the absence of C-NHEJ, two forms of A-EJ, which 
appear to be potentially distinct based on both different pref-
erences for junctional MHs and differential reliance on Ku, 
catalyze  the  physiological  process  of  CSR.  One  form  of   
A-EJ, that operates in the absence of XRCC4 or Lig4, utilizes 
Ku and either Lig1 or Lig3 and, at least in the context of 
CSR, is almost totally reliant on junctional MHs. Given its 
apparent dependence on Ku, this form of A-EJ may, as has 
been suggested (Lieber et al., 2008), reflect the use of the   
upstream  components  of  C-NHEJ  with  a  different  ligase   
(Lieber et al., 2008); although it remains possible that there 
DISCUSSION
Recent work has established the role of A-EJ in mammalian 
DNA repair and made this pathway a major current focus of 
the DNA repair field. Yet, the nature of A-EJ has remained 
enigmatic. In particular, other than recent studies that impli-
cate the MRN complex in chromosomal A-EJ (Deng et al., 
2009; Dinkelmann et al., 2009; Rass et al., 2009; Xie et al., 
2009), little has been forthcoming regarding the identity of 
chromosomal A-EJ components. In addition, although A-EJ 
is often discussed as a single pathway, it has remained possible 
that there are multiple A-EJ pathways that use at least some 
different components. Our current studies provide several 
Figure 4.  Time course for IgG1 CSR in Ku70/H/HL+, Ku70/Lig4/H/HL+, and WT-H/HL+ B cells stimulated with CD40 plus IL-4.  
(a) Representative FACS plots for IgG1 CSR quantification in B cells from the indicated backgrounds stimulated with CD40 plus IL-4. IgG1 FACS was 
recorded at day 2.5, 3.5, and 4.5. AID, AID/ B cells used as negative controls for CSR. Percentage of B220+IgG1+ cells that have undergone CSR is shown 
for each genotype at each time point. Data shown are representative of three independent B cell stimulation experiments, with one mouse of each geno-
type per experiment. (b) Quantification of CSR levels at days 2.5, 3.5, and 4.5 from the beginning of the in vitro stimulation. Data are based on at least 
three mice per genotype used in three separate experiments. Table S1 contains the summary of all FACS experiments.424 Ku influences CSR in the absence of DNA ligase 4 | Boboila et al.
substantial levels of CSR direct joins. We conclude that this 
second (Ku plus Lig4-independent) form of A-EJ is totally 
distinct from C-NHEJ and must use a largely different set   
of components.
Prior studies found that CSR was abrogated by Ku70- or 
Ku80-deficiency, leading to the common assumption that 
are other differences from C-NHEJ. Our current findings 
further  demonstrate  a  second  form  of  A-EJ  during  CSR   
that functions in the simultaneous absence of both the DSB 
recognition  component  (Ku70)  and  the  specific  ligation 
component (Lig4) of C-NHEJ. This second form of A-EJ, 
while also biased toward CSR junctional MHs, generates 
Figure 5.  The Ku-dependent A-EJ pathway uses a distinct mechanism for S region joining. (a) Classical NHEJ performs both direct (left) and MH-
mediated (right) end-joining. Direct joining occurs when DNA ends are joined either immediately, or after processing (removal of overhangs or fill-in by 
polymerases). MH-mediated joining (right) is facilitated by base-pairing interactions between short stretches of nucleotides at or near the ends of the 
DSB. (b) MH length in S-S1 (left) and S-S (right) junctions from Ku70/HL, Ku70/Lig4/HL, Lig4/HL and WT/HL B cells stimulated in culture 
with CD40 plus IL-4. Ku70-, Ku70/Lig4-, and Lig4-deficient cells have more S-S1 (left) and S-S (right) joins with longer MH than WT. Data shown 
are based on 86 or more independent sequences per genotype for S-S1 junctions and 41 or more independent sequences for S-S junctions. At least 
three mice per genotype in three independent experiments were used for S-S1 junctions and one Ku70/HL mouse, two Ku70/Lig4/HL mice, 
three Lig4/HL, and three WT-HL mice in three independent experiments were used for S-S junctions. A detailed summary of all S region junction 
isolation experiments and mice is presented in Table S4. (C) Percentage of direct S-S1 (left) and S-S (right) joins in Ku70/HL, Ku70/Lig4/HL, 
Lig4/HL, XRCC4/HL and WT/HL B cells. Ku70 and Ku70Lig4-deficient cells have significantly more direct S-S1 and S-S joins than Lig4 germline-
deficient cells. *, XRCC4 junctions were acquired and published previously (Yan et al., 2007) and are shown here for comparison. Two-tailed Student’s t 
test was used for p-value. Data shown are based on 86 or more independent sequences per genotype for S-S1 junctions and 41 or more independent 
sequences for S-S junctions. At least three mice per genotype in three independent experiments were used for S-S1 junctions, and one Ku70/HL 
mouse, two Ku70/Lig4/HL mice, three Lig4/HL, and three WT-HL mice in three independent experiments were used for S-S junctions. N, number 
of independent sequences.JEM VOL. 207, February 15, 2010 
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direct end joining of oligonucleotide substrates (Chen et al., 
2000; Cotner-Gohara et al., 2008). Thus, if the end preference 
observed in biochemical studies holds in Ku70-deficient cells, 
our findings might be explained by Lig3 preferentially gaining 
access to DNA ends in Ku70-deficient cells and Lig1 preferen-
tially accessing ends in Ku-70 proficient, Lig4-deficient cells.
In conclusion, our studies demonstrate the existence of an 
A-EJ pathway that functions to generate substantial levels of 
chromosomal IgH CSR joins in activated B cells that lack both 
DSB recognition and joining components of the C-NHEJ 
pathway. This finding firmly demonstrates the existence of a 
physiologically functional A-EJ pathway that is distinct from 
C-NHEJ. In addition, we find that the previously described 
MH-based A-EJ pathway of CSR that catalyzes CSR in the 
absence of either XRCC4 or Lig4 is substantially influenced 
by Ku; thus, this pathway might be a variant of C-NHEJ that 
uses a different ligase; although other possibilities including a 
distinct, Ku dependent, A-EJ pathway can also be considered.
MATERIALS AND METHODS
Mouse  strains.  Ku70/,  Lig4/  CD21CreXrcc4c/c,  and  Ku80/  HL 
mice have been previously described (Gu et al., 1997, Frank et al., 1998, Yan 
et al., 2007, Casellas et al., 1998). Ku70/Lig4/HL mice were obtained by 
breeding double-heterozygous Ku70+/Lig4+/HL mice. Animal protocols 
were approved by the Institutional Animal Care and Use Committee of   
Children’s Hospital (Boston, MA).
Splenic B cell purification and culture. Mature B cells were isolated and 
enriched from the spleen and stimulated with CD40/IL-4 to induce CSR   
to IgG1 and IgE as described (Yan et al., 2007). For IgG3 and IgG2b CSR,   
B cells were stimulated with LPS and dextran-conjugated IgD as de-
scribed (Cheng et al., 2009). For IgA CSR, B cells were stimulated with 
LPS (25 µg/ml), dextran-conjugated IgD (3 ng/ml), IL-4: 10 ng/ml, IL-5: 
1.5 ng/ml and TGF: 2 ng/ml. Cytokine sources: CD40: eBioscience, IL-4: 
eBioscience, IL-5: BD dextran-conjugated IgD: Fina BioSolutions LLC. 
Proliferation studies were conducted on aCD40/IL-4 stimulated splenic cells 
enriched with B220 magnetic beads (Miltenyi Biotec) and cells were counted 
every 24 h starting at 1.5 d post-enrichment to ensure that the majority of 
the cells in culture were B cells. Surface expression was recorded by FACS. 
ELISPOT and ELISA were performed as described (Yan et al., 2007) at 
days 4 and 6 of culture, respectively. B cell hybridoma fusions were per-
formed at day 4 of culture and hybridomas were screened by ELISA after 
1 wk of selection.
S region junction isolation and analysis. S-S1 and S-S junctions 
were amplified from B cells stimulated in culture with CD40 plus IL-4   
or from hybridomas derived from the above cultures with primers described 
previously (Yan et al., 2007) and National Center for Biotechnology Informa-
tion Blast was used for sequence analysis. Calculation of statistical significance 
was done using the two-tailed Student T test.
Online supplemental material. Fig. S1 shows a CSR timecourse in Ku70/ 
HL and Ku80/HL mice. Fig. S2 shows CSR-related DNA recombination 
events in IgG1+ and IgE+ Ku70/HL and Ku70/Lig4/HL hybridomas. 
Fig. S3 shows IgA CSR in Ku70/HL B cells. Table S1 is a summary of all 
FACS experiments. Table S2 is a summary of all ELISA experiments. Table S3 
is a summary of all hybridoma fusion data. Table S4 is a summary of all S   
region function data.
We thank Klaus Rajewsky, Bjoern Schwer, Monica Gostissa, and Maria-Vivienne 
Boboila for discussions and critical reading of the manuscript.
Ku70 and Ku80 are essential for end joining during CSR 
(Honjo et al., 2004). However, Ku70- or Ku80-deficient 
cells, as assayed at that time, had severe proliferation defects, 
which also were suggested to potentially contribute to their 
severe CSR impairment (Manis et al., 1998, 2002; Chaudhuri 
and Alt, 2004; Chaudhuri et al., 2007). Our current stimu-
lation conditions lead to substantially increased CSR in WT 
cells and also appear to obviate the very severe proliferation 
defects previously observed in Ku-deficient B cells. Under 
these stimulation conditions, we confirm that CSR indeed is 
impaired in Ku-deficient B cells; but, on the other hand, we 
also find that Ku-deficient B cells are capable of undergoing 
substantial CSR. Indeed, Ku70- or Ku80-deficient B cells 
reach steady-state CSR levels that range from 25–50% those 
of WT B cells, which are similar in range to those found in 
XRCC4- or Lig4-deficient B cells. Likewise, our time course 
experiments confirmed that CSR in the absence of Ku or Ku 
plus Lig4 is quite robust; although perhaps slightly delayed 
kinetically as compared with that of WT B cells reminiscent 
of  findings  of  CSR  in  Lig4-deficient  CH12  cells  (Han   
and Yu, 2008).
The spectrum of CSR junctions differs between Ku70-
deficient  or  Ku70-  plus  Lig4-deficient  versus  Lig4-  or 
XRCC4-deficient B cells. Thus, XRCC4- or Lig4-deficient 
junctions are nearly all MH mediated, whereas the junctions 
that occur in the absence of Ku70 or Ku70 plus Lig4, al-
though still biased toward MH, have a substantial percentage 
of direct joins. These findings are consistent with findings of 
increased, although not to the same degree, use of MH in ISceI-
mediated DSB junctions recovered from XRCC4 versus   
Ku-deficient Chinese hamster organ cells (Guirouilh-Barbat 
et al., 2004, 2007). Ku was previously thought to function in 
DNA repair only via C-NHEJ; thus, our finding that Ku   
actually promotes MH-mediated A-EJ during CSR in the 
absence of Ligase 4 was unexpected. The Ku heterodimer 
binds to ends of DSBs and then recruits other C-NHEJ repair 
factors (for review see Rooney et al., 2004), while also pro-
tecting the broken DNA ends from degradation. However, 
we find that nearly all CSR DSBs in Ku-proficient/Lig4-
  deficient cells are joined via MHs, which presumably requires 
end resection; whereas CSR DSBs in Ku plus Lig4-deficient 
B cells have a higher frequency of direct joins. One possible 
explanation for these seemingly contradictory findings would 
be that Ku can preferentially stabilize S region ends held by 
microhomologies.  Alternatively,  in  the  absence  of  Ku70, 
end-modifying polymerases, such as TdT, pol µ, or pol  
might gain access to DNA ends and perform nucleotide ad-
ditions to generate “occult” end-homology (Komori et al., 
1996) that cannot be distinguished from “direct” joins. In this 
context, Pol µ has been shown to have TdT-like activity and 
to add nontemplate nucleotides even in the absence of Ku, 
XRCC4, or Lig4 (Gu et al., 2007). A further possibility is 
that  Lig1  and  Lig3  may  be  differentially  involved  in  the 
Ku70-dependent, MH-mediated A-EJ pathway versus the 
Ku70-independent pathway and, thereby, provide the end 
preference. In biochemical assays, Lig3 but not Lig1 performs 426 Ku influences CSR in the absence of DNA ligase 4 | Boboila et al.
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